Piracetam for Treatment of Cocaine Addiction, Phase II - 4

University of Pennsylvania logo

University of Pennsylvania

Status and phase

Withdrawn
Phase 1

Conditions

Cocaine-Related Disorders

Treatments

Drug: Piracetam

Study type

Interventional

Funder types

Other
NIH

Identifiers

NCT00000199
K02-00238-4
NIDA-00238-4
K20DA000238 (U.S. NIH Grant/Contract)

Details and patient eligibility

About

The purpose of this study is to follow patients in Phase I of an inpatient study in an eight week open label assessment of piracetam in an outpatient treatment program.

Sex

All

Volunteers

No Healthy Volunteers

Inclusion and exclusion criteria

Please contact site for information.

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems